NCT04835987

Brief Summary

Esophageal surgery is a complex surgery, with high post-operative morbidity and mortality. The incidence of complications associated with esophagectomy varies from 17% to 74%, in the literature. A section of vagus nerves is conventionally performed during esophagectomy for cancer, because of oncological margins. The vagus nerve is responsible for the parasympathetic innervation at the gastrointestinal level, but also at the cardiac and pulmonary level. The post-operative morbidity of these procedures could be linked in part to the bilateral section of the vagus nerves, because of their impact on the autonomous regulation of this vital functions. The main objective of the study is to find a modification of the sympathomimetic balance pre and post operatively, in patients undergoing esophagectomy.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
2.6 years until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

November 24, 2023

Status Verified

June 1, 2023

Enrollment Period

3 months

First QC Date

March 26, 2021

Last Update Submit

November 21, 2023

Conditions

Keywords

EsophagectomysurgeryHolter-ECG

Outcome Measures

Primary Outcomes (2)

  • Analysis of Standard deviation of all NN (SDNN) (ms)

    Analysis of Standard deviation of all NN (SDNN) intervals, over the entire registration period, provides information on global variability. Measured by Holter results. Day 0 = surgery

    before surgery

  • Analysis of Standard deviation of all NN (SDNN) (ms)

    Analysis of Standard deviation of all NN (SDNN) intervals, over the entire registration period, provides information on global variability. Measured by Holter results. Day 0 = surgery

    day 7 to day 90

Secondary Outcomes (10)

  • HF activity

    before surgery : Day -82, Day -30, Day -1

  • LF activity

    before surgery : Day -82, Day -30, Day -1

  • LF/HF ratio

    before surgery : Day -82, Day -30, Day -1

  • HF activity

    after surgery : day 7, day 60, day 90

  • LF activity

    after surgery : day 7, day 60, day 90

  • +5 more secondary outcomes

Interventions

Holter ECGDIAGNOSTIC_TEST

Measurement of the modification of the sympathomimetic balance

QuestionaryBEHAVIORAL

Lifestyle questionary (time spent in front of television, physical activity)

PupillometryDIAGNOSTIC_TEST

Monitoring of nociception and autonomic nervous system by pupillometry in intraoperative.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

population aged over 18 years with esophagectomy for cancer

You may qualify if:

  • Esophagectomy for cancer
  • written and oral agreement

You may not qualify if:

  • pregnant women,
  • patients with permanent atrial fibrillation,
  • patients with pace-maker
  • Patients under guardianship/curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire de Saint-Etienne

Saint-Etienne, 42055, France

Location

MeSH Terms

Conditions

Esophageal Neoplasms

Interventions

Electrocardiography, Ambulatory

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases

Intervention Hierarchy (Ancestors)

ElectrocardiographyHeart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisMonitoring, AmbulatoryMonitoring, Physiologic

Study Officials

  • EVE HUART, MD

    CHU ST ETIENNE

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2021

First Posted

April 8, 2021

Study Start

December 1, 2023

Primary Completion

March 1, 2024

Study Completion

September 1, 2024

Last Updated

November 24, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations